Skip to main content
4DMEDICAL LIMITED logo

4DMEDICAL LIMITED — Investor Relations & Filings

Ticker · 4DX ISIN · AU0000095416 LEI · 9845000A8F12A6A6FD75 ASX Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 546 across all filing types
Latest filing 2025-10-12 Share Issue/Capital Cha…
Country AU Australia
Listing ASX 4DX

About 4DMEDICAL LIMITED

https://4dmedical.com/

4DMedical Limited develops non-invasive respiratory imaging solutions centered on its proprietary XV Technology. This platform utilizes advanced algorithms to transform standard X-ray sequences into four-dimensional quantitative data, visualizing regional lung function in motion. The flagship XV Lung Ventilation Analysis Software (XV LVAS) provides clinicians with detailed maps of airflow distribution throughout the respiratory cycle, facilitating the early detection and monitoring of chronic conditions such as COPD, asthma, and interstitial lung disease. By providing objective, high-resolution insights into lung ventilation without the limitations of traditional pulmonary function tests, the company's cloud-based diagnostic tools aim to improve clinical workflows and patient management. The integration of artificial intelligence further enhances its capability to deliver precise, automated lung tissue analysis.

Recent filings

Filing Released Lang Actions
Application for quotation of securities - 4DX 8 pages 25.0KB
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Appendix 2A - Application for quotation of securities' and is an official announcement to the ASX regarding the quotation of securities resulting from options exercised or convertible securities converted. It details the number and type of securities to be quoted, issue dates, consideration, and the issued capital following quotation. This is a formal application for listing new securities on the exchange, not a financial report or earnings release. It fits the category of Share Issue/Capital Change announcements, as it relates to new securities being issued and quoted on the exchange.
2025-10-12 English
Cleansing Notice 1 page 214.6KB
Share Issue/Capital Change Classification · 95% confidence The document is a cleansing notice under section 708A(5)(e) of the Corporations Act 2001 (Cth) related to the issue of shares by 4DMedical Limited. It details the issuance of shares on exercise of options and compliance with relevant disclosure provisions. The document is short (2072 characters) and serves as a regulatory announcement about share issuance without disclosure, rather than a full financial report or detailed capital update. This fits the category of Share Issue/Capital Change announcements, which cover new share issues and related notices.
2025-10-12 English
Application for quotation of securities - 4DX 7 pages 21.2KB
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Appendix 2A - Application for quotation of securities' and contains detailed information about securities issued, transferred, or re-classified due to options being exercised or convertible securities being converted. It includes specifics such as the number of securities to be quoted, issue dates, issue prices, and the classes of securities involved. This type of document is a formal application to the stock exchange (ASX) for the quotation of new or additional securities. It is not a financial report, earnings release, or management discussion, nor is it an announcement of voting results or a regulatory filing in the general sense. The document is focused on capital market activity related to securities issuance and quotation. Therefore, it fits best under the category of Share Issue/Capital Change (SHA). The document length (8244 characters) and content confirm it is the actual application, not just a brief announcement or notice, so it is not RPA or RNS.
2025-10-09 English
Notification regarding unquoted securities - 4DX 7 pages 22.4KB
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities' and contains detailed information about the issuance of unquoted securities under an employee incentive scheme by 4DMedical Limited. It includes specifics such as security codes, number of securities issued, issue dates, and mentions key management personnel involved. The document is a formal notification to the ASX regarding securities issuance, which aligns with announcements about new share issues or capital changes. It is not a full financial report, earnings release, or management discussion, but rather a regulatory announcement about capital changes. Therefore, the appropriate classification is 'Share Issue/Capital Change' (SHA). The document length (7117 characters) supports it being a full notification rather than a brief announcement or a report publication notice.
2025-10-06 English
4DMedical secures $22.6 million via exercise of options 2 pages 222.8KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 03 October 2025, detailing the exercise of options by 4DMedical, resulting in a capital inflow of $22.6 million. It discusses the company's cash balance, strategic investments, and further in-the-money options that could provide additional capital. The content focuses on financing activities, specifically the exercise of stock options and the resulting impact on the company's capital structure. There are no financial statements or detailed financial performance data presented, nor is this a report or presentation. The document is a capital/financing update announcing the successful exercise of options and the resulting capital secured by the company.
2025-10-02 English
Appendix 2A 20 pages 506.7KB
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Appendix 2A Application for quotation of securities' and contains detailed information about the application for quotation of securities on the ASX (Australian Securities Exchange). It includes sections on entity details, type of securities issued, dates of issue, and other regulatory compliance information related to securities quotation. This type of document is a formal application to list or quote new securities on the exchange, which is a regulatory announcement related to capital changes. It is not a financial report, earnings release, or management discussion. It is specifically an application for quotation of securities, which aligns with announcements about share issues or capital changes. Therefore, the most appropriate classification is 'Share Issue/Capital Change' (SHA). The document length and detail confirm it is not a brief announcement or a report publication notice, but a substantive regulatory filing for capital change.
2025-10-01 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.